Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccines, Combined”

734 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 734 results

Very early researchNot Yet RecruitingNCT06156267
What this trial is testing

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

Who this might be right for
Pancreatic Cancer
Fudan University 30
Early research (Phase 1)Ended earlyNCT01810016
What this trial is testing

NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Ludwig Institute for Cancer Research 8
Early research (Phase 1)Study completedNCT00001044
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Large-scale testing (Phase 3)Study completedNCT02058563
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

Who this might be right for
RubellaMumpsMeasles
GlaxoSmithKline 996
Testing effectiveness (Phase 2)Study completedNCT00032045
What this trial is testing

Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00325130
What this trial is testing

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 1,042
Large-scale testing (Phase 3)Study completedNCT00514709
What this trial is testing

Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 1,843
Testing effectiveness (Phase 2)Study completedNCT00617409
What this trial is testing

To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid

Who this might be right for
Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 69
Early research (Phase 1)Study completedNCT01675765
What this trial is testing

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Aduro Biotech, Inc. 60
Post-approval studies (Phase 4)Study completedNCT05289271
What this trial is testing

Safety, Tolerability, and Immunogenicity of Vaxelis™ in Children Previously Vaccinated With Vaxelis™ or Hexyon™ (V419-016)

Who this might be right for
Vaccines, CombinedHexavalent Vaccine
Merck Sharp & Dohme LLC 168
Testing effectiveness (Phase 2)Study completedNCT01876212
What this trial is testing

Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Walter J. Storkus 15
Post-approval studies (Phase 4)Looking for participantsNCT06068530
What this trial is testing

Mass Vaccine and Drug Administration, Bangladesh

Who this might be right for
Plasmodium Falciparum Malaria
University of Oxford 10,000
Early research (Phase 1)Study completedNCT01966289
What this trial is testing

SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 18
Testing effectiveness (Phase 2)Looking for participantsNCT06751849
What this trial is testing

Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Who this might be right for
Advanced NSCLC
The First Affiliated Hospital of Nanchang University 10
Early research (Phase 1)Study completedNCT00001026
What this trial is testing

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Study completedNCT01171989
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Who this might be right for
TetanusDiphtheriaHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 391
Testing effectiveness (Phase 2)Study completedNCT00001685
What this trial is testing

Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase

Who this might be right for
MelanomaNeoplasm Metastasis
National Cancer Institute (NCI) 114
Large-scale testing (Phase 3)Study completedNCT02817451
What this trial is testing

DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 53
Early research (Phase 1)Study completedNCT01701336
What this trial is testing

Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients

Who this might be right for
Hepatitis C
ReiThera Srl 9
Testing effectiveness (Phase 2)Study completedNCT00574704
What this trial is testing

Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Who this might be right for
Perennial Allergic RhinoconjunctivitisHouse Dust Mite Allergy
Cytos Biotechnology AG 40
Load More Results